Publication | Open Access

Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial

ImmunologyPharmacologyTherapeutic EfficacyAntibody ScreeningAntibody EngineeringPharmacotherapyImmunotherapyMedicinePhase 1Dose-escalation Clinical TrialHealthy Adults